Nephros Expands into Puerto Rico to Deliver Differentiated Water Filtration Solutions Across Medical and Commercial Sectors
Rhea-AI Summary
Nephros (Nasdaq: NEPH) announced expansion into Puerto Rico on Feb 13, 2026, targeting medical and commercial water filtration needs.
The company estimates a $10 million Puerto Rico market opportunity across healthcare ($3M), foodservice ($3M), hotels ($1M), other hospitality ($1M) and service contracts/replacements ($1M), and will offer local Spanish support, rapid fulfillment and on-site installation.
Positive
- $10M Puerto Rico market opportunity
- Healthcare segment opportunity: $3M
- Localized Spanish support and on-site installation
- Service contracts & replacements valued at $1M
Negative
- Total Puerto Rico opportunity is modest at $10M
- Market described as complex, fragmented, which may slow scaling
News Market Reaction – NEPH
In the Feb 13 session, NEPH gained 9.04%, reflecting a notable positive market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 11 | Education initiative | Positive | -2.9% | Launch of Nephros Water Institute to expand national water-safety education. |
| Nov 06 | Quarterly earnings | Positive | -8.6% | Strong Q3 2025 results with revenue and net income growth and ongoing profitability. |
| Oct 30 | Earnings call setup | Neutral | +2.9% | Announcement of schedule and access details for Q3 2025 conference call. |
| Oct 08 | Product launch | Positive | -9.2% | Launch of 19-Series PFAS point-of-use filter for potable water protection. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent positive product, education, and earnings news often coincided with negative next-day price reactions.
Over the past several months, Nephros has reported multiple growth-oriented milestones. In Q3 2025, it delivered net revenue of $4.8M and net income of $0.3M, its fourth consecutive profitable quarter, yet the stock fell 8.61% the next day. The launch of a new PFAS filter on Oct 8, 2025 and the creation of the Nephros Water Institute on Dec 11, 2025 also saw negative price reactions. Today’s Puerto Rico expansion fits this pattern of strategically positive news against a historically cautious market response.
Key Terms
waterborne pathogen medical
point-of-use purification technical
point-of-use filtration technical
pfas medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH ORANGE, N.J., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced its entry into the Puerto Rican market, targeting high-need applications such as ice machines, drinking fountains, bottle fillers, and sterile processing environments.
With a proven track record in infection control and water purity, Nephros brings a differentiated approach to water filtration, delivering advanced products with faster service and local-language support in a region long underserved by premium filtration providers.
Puerto Rico Market
With increasing focus on public health, waterborne pathogen risk, and infrastructure-driven water quality challenges, Nephros believes its infection-control filtration solutions serve an unmet need I Puerto Rico. Nephros’ filtration solutions offer important safeguards to support point-of-use purification for drinking water equipment, plumbing outlets, and instrument processing across key sectors such as healthcare, foodservice, and hospitality. The company estimates that the Puerto Rican market presents a
- Healthcare –
$3M - Foodservice –
$3M - Hotels –
$1M - Other Hospitality –
$1M - Service Contracts & Replacements –
$1M
“We believe Puerto Rico is a massively underserved market when it comes to reliable, high-quality filtration—particularly for environments where bacteria and harmful contaminants in water can have serious consequences,” said Robert Banks, President and CEO of Nephros. “Our entry into Puerto Rico is a natural extension of our core strategy: leveraging best-in-class technology and execution to meet critical water safety needs.”
Local Service, Rapid Fulfillment, Language-Specific Support
Nephros plans to differentiate itself by offering:
- Rapid response and fulfillment from a dedicated inventory network
- On-site installation and scheduled filter replacements
- Customer support and technical documentation in Spanish
- Point-of-use filtration for microbial control and regulated drinking water contaminants such as lead and PFAS
This localized approach ensures compliance, reliability, and ease of use for customers across the island. Nephros' move into Puerto Rico aligns with its broader growth strategy—expanding into adjacent markets beyond traditional patient care to support water safety within hospitality and foodservice. “We’re inspired by the momentum, energized by the cultural pride, and ready to serve. This market launch underscores our belief that small, agile companies with the right technology and team can create meaningful impact even in complex, fragmented markets,” added Banks.
About Nephros
Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within healthcare and commercial markets, offering both proactive and emergency solutions for water management.
For more information about Nephros, please visit nephros.com.
Forward-Looking Statements
This release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding Nephros’ beliefs about the Puerto Rico market, including the size of the market and Nephros’ ability to attain market share, the expected benefits of its filtration products and other statements that are not historical facts, including statements that may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including Nephros’ dependence on third-party manufacturers, distributors and researchers, changes in competitive conditions and regulatory reforms. These and other risks and uncertainties are detailed in Nephros’ reports filed with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2024, which it may update in Part II, Item 1A – Risk Factors in its Quarterly Reports on Form 10-Q that it has filed following such Form 10-K. Nephros does not undertake any responsibility to update the forward-looking statements in this release.
Investor Relations Contacts:
Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com
Robert Banks, CEO
Nephros, Inc.
(201) 343-5202 x110
robert.banks@nephros.com
